NOVEMBER 2023LIFE SCIENCES REVIEW1OMNIAB, INC. (NASDAQ: OABI)ISSN 2831-8331E DI T IO NDiscovering High-Quality Therapeutic Antibodies; Unparalleled Antibody DiscoveryANTIBODY DRUG DISCOVERY LIFESCIENCESREVIEW.COMNOVEMBER - 13 - 2023
Page 2 >